You just read:

Intarcia Announces Acquisition of Phoundry Pharmaceuticals - Second Pipeline Deal of 2015 Secures Novel Peptide Therapeutics to Combine with ITCA 650 Targeting Next Gen Diabetes & Obesity Therapies

News provided by

Intarcia Therapeutics, Inc.

Sep 24, 2015, 10:00 ET